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Summary Infection has long been suspected as a possible factor in the aetiology of leukaemia and lymphoma. If seasonal variation in the
onset of disease could be shown in any of the diagnostic subgroups of leukaemia or tymphoma, this would provide supportive evidence of an
aetiology linked to exposure to infection. All cases in the Manchester Children's Tumour Registry (aged 0-14 years at diagnosis) with acute
tymphoblastic leukaemia (ALL), acute non-lymphocytic leukaemia (ANLL), Hodgkin's disease (HD) or non-Hodgkin Iymphoma (NHL) between
1 January 1954 and 31 December 1996 were included in an analysis of seasonal variation in the month of first symptom and the month of
diagnosis. Cases of common acute lymphoblastic leukaemia (c-ALL) diagnosed from 1979 onwards were also analysed separately. The
groups considered for analysis were: all cases of ALL (n = 1070), ALL diagnosed between 18 and 95 months of age (n =730), ALL diagnosed
over 95 months of age (n =266), c-ALL (n =309), ANLL (n =244), all infant acute leukaemias (ALL and ANLL under 18 months: n = 107), HD
(n = 166) and NHL (n = 189). Using the Edwards method, both c-ALL and HD demonstrated significant seasonal variation (P = 0.037 and
0.001 respectively) in date of first symptom, with peaks occurring in November and December respectively. Using this method, no indication
of seasonal variation was found in the other diagnostic groups for date of first symptom or in any of the diagnostic groups for date of
diagnosis. For comparison with a previous study, a further analysis based on date of diagnosis for all ALL cases, using summer-winter ratios.
showed a significant summer excess. These results provide supportive evidence for an infectious aetiology for c-ALL and HD. and possibly
for all ALL, which warrants further investigation.
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Infection has long been suspected as a possible factor in the
aetiology of leukaemia (Kellett, 1937). a possibility supported by
recent york (Greaves. 1988: Kinlen. 1988: 1995: Greaves and
Alexander. 1993). However. no specific agent has yet been
identified. Evidence for the involvement of infections in certain
lymphomas is more direct. Notably. Epstein-Barr virus (EBV)
appears to be aetiologically linked to Burkitt's lvmphoma (Day et
al. 1985) and Hodgkin's disease (Hummell et al. 1992: Armstrong
et al. 1993: Kahn and Coates. 1994: Weinreb et al. 1996).
Ifinfections are involved in the aetioloay ofchildhood leukaemia
and lymphoma. some seasonal pattern of onset might be expected.
Past studies into seasonal variation of date of onset of acute
leukaemia and lymphoma have been limited by the relatively poor
quality and quantity of data. or inadequate statistical testinc of the
apparent peak in incidence. This has given rise to a number of
conflicting reports as to wihether apeak in incidence exists and. ifso.
when it occurs (Lambin and Gerard. 1934: Forkner. 1938: Scanu.
1954: Hayes. 1961: Lee. 1962: Fraumeni. 1963: Bjelke. 1964:
Gunz and Spears. 1968: Walker and Van Noord. 1982). For acute
lymphoblastic leukaemia. a sigiificant excess has recently been
reported in the frequency of cases diagnosed in summer (defined
as May-October) compared with %vinter (Noxvember-April). again
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prox iding possible support for an infectious aetiology for this condi-
tion (Badrinath et al. 1997).
Given the current interest in the possible aetiological role of
infections. we have performed a comprehensixe study of studied
seasonal variation The Manchester Children's Tumour Registrx
(MCTR) (Blair and Birch. 1994) has high-qualits population-
based data in sufficient quantity to enable the use of powerful
statistical techniques. We therefore hoped to achieve a more reli-
able assessment of anv seasonal fluctuations in onset.
MATERIALS AND METHODS
Cases for the studv w-ere ascertained from the MCTR. All
instances of malignant disease and certain other neoplastic condi-
tions (patients aged 0-14 years) diagnosed since 1954 who wvere
resident within a defined geographical area in the north-vest of
England. including Greater Manchester and Lancashire. at the
time of diagnosis haxe been registered with the MCTR. The
majority of cases are notified directly bv clinicians at the time of
diagnosis. but a smaHl number are ascertained through death
registrations and cross-checkingv with pathologv records and other
cancer registries. For each recistration. detailed abstracts or copies
are taken from medical records and retained for future reference.
From the outset. biopsy material from all solid tumours. including
lymphomas. has been obtained from all operations and post-
mortems. This has been revieved by pathologists who are experi-
enced in paediatric tumour pathologv. thus ensuring diagnostic
accuracv. For leukaemias. over 70%7c of cases viere diagnosed by
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one ofthree specialist paediatric haematologists. In addition. there
has also been a national central review of leukaemia cases since
1980 and of lymphoma since 1977. Material is stored by the
MCTR so that diagnoses can be reviewed when new diagnostic
techniques are developed or diagnostic classifications are revised
(Birch. 1988).
Final diagnoses were coded using both the topographv and
morphology codes from the second edition of the International
Classification of Diseases for Oncology (ICD-O) (World Health
Organization. 1990) and were then allocated to diagnostic groups
using a modification of the classification scheme based on ICD-O
and developed for childhood cancer (Birch and Marsden. 1987).
All cases in the MCTR diagnosed with ALL. ANLL. HD or
NHL between 1 January 1954 and 31 December 1996 inclusive
were entered into the study. The data abstracted for each case
consisted of date of first symptom. date ofdiagnosis. age at diag-
nosis and diagnostic group. In addition. for ALL, immunopheno-
type was available on a population base for cases diagnosed from
1979 onwards (before this date immunophenotyping was available
for only a proportion ofcases). The groups considered for analysis
were: all cases of ALL. ALL diagnosed between 18 and 95
months: ALL diagnosed over 95 months: c-ALL; ANLL; all infant
acute leukaemias (ALL and ANLL under 18 months): HD: and
NHL. Date offirst symptom had been recorded prospectively from
the outset of the MCTR and is defined as 'the date the patient was
last known or thought to be well'. Date of diagnosis is defined as
'the date when the definitive diagnostic biopsy or bone marrow
sample was taken'. Using this information, cases within each of
the above diagnostic groups were allocated to a month of first
symptom and to a month ofdiagnosis.
Statistical analysis
Firstly, to test for any departure from a uniform distribution
throughout the year. a chi-squared test for heterogeneity was used.
However, this offers limited information. as we were interested in
the detection of reasonably smooth trends over the year. A more
suitable test for the detection of a sinusoidal curve within a 12-
month period (one peak and one trough) is that suggested by
Edwards (1961). This technique considers the data to be in the
form of the rim of a circle, divided into equal sectors corre-
sponding to time intervals (12 intervals in this case, reflecting the
number of months in a year) and a number in each rim-sector
representing the number of observed events in that month. This
number is then replaced by a weight. determined by any monot-
onic function of this number. If no cyclical trend is apparent. then
theexpected centre ofgravity wvill be at the centre ofthe circle, but
any excess ordeficit in neighbouring sectors will have a consistent
effect on the position ofthe centre ofgravity whose distance from
the centre (amplitude) will have a known probability distribution
under the null hypothesis and whose direction will indicate the
position of the maximum and the minimum liability. The test
statistic is as follows:
[8n/(X;\n,)1][(X\n
0)-
+ (on 0)2]
0 =2rni/ 2. n =number of cases in month for i = 1. 12
Under the null hypothesis. this test statistic has a sampling
distribution that approximates to the chi-squared distribution on
two degrees offreedom. Marrero (1983) assessed the adequacy of
a number of statistical techniques for analysing, seasonal Xariation
Table 1 Monthy frequenaes of date of first symptom for ALL ANLL c-ALL ALL and ANLL (<18 months only). HD and NHL patients entered in the study
Type Age at diagnosis (months) Jan Feb LMar Apr May June July Aug Sept Oct Nov Dec Total
Acute lymphoblastic leukaemia 0-179 89 79 81 107 104 77 75 95 73 89 80 106 1055
18-95 58 56 57 76 70 48 55 69 45 56 57 72 719
>95 25 19 20 24 28 20 15 18 21 28 17 29 264
Acute non-ymphocybc leukaemia 0-179 25 20 18 24 20 16 16 20 21 19 15 22 236
Common acute lymphoblastic leukaemia 0-179 27 17 20 28 25 16 19 28 20 32 31 37 300
Infant leukaemia (ALL and ANLL) <18 8 4 8 11 9 10 5 13 9 10 7 9 103
Hodgkin's disease 0-179 20 18 7 14 9 12 10 7 9 18 12 27 163
Non-Hodgkin Iymphoma 0-179 20 14 12 19 14 13 14 15 18 14 14 16 183
Table 2 Monthly frequencies of date of diagnosis for ALL, ANLL, c-ALL ALL and ANLL (<18 months only), HD and NHL patients entered in the study
Type Age at diagnosis (months) Jan Feb Mar Apr May June July Aug Sept Oct Nov Dec Total
Acute lymphoblastic leukaemia 0-179 92 87 75 88 106 97 87 101 89 94 85 69 1070
18-95 61 60 53 60 74 70 57 73 59 60 59 44 730
>95 26 24 19 23 27 18 23 19 22 28 20 17 266
Acute nonfymphocyic leukaemia 0-179 21 23 18 23 22 18 26 18 13 21 24 17 244
Common acute tymphoblastic leukaemia 0-179 29 28 19 19 28 29 17 33 21 29 31 26 309
Infant leukaemia (ALL and ANLL) <18 8 4 6 8 8 12 9 12 10 11 10 9 107
Hodgkin's disease 0-179 21 16 13 18 17 12 9 10 12 15 12 11 166
Non-Hodgkin lymphoma G-179 18 14 16 15 19 12 14 21 15 12 13 20 189
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Table 3 Results of the analyses performed upon the monthly frequencies for dates of first symptom and diagnosis
Age at H eneity test Edwards' test
dignosis (12-month period)
x2 d.f. P-value Peak month Amplitude x2 d.f. PLvalue
Date offirst syrnptom 0-179 19.35 11 0.055 March 0.0545 1.57 2 0.456
Acute tymphoblastic leukaemia 18-95 17.17 11 0.103 March 0.0737 1.95 2 0.377
>95 11.00 11 0.443 January 0.0989 1.29 2 0.525
Acute nonlymphocytic leukaemia 0-179 5.42 11 0.909 February 0.0907 0.97 2 0.610
Common acute tymphoblastic leukaemia 0-179 19.28 11 0.056 November 0.2107 6.66 2 0.037
Infant leukaemia (ALL and ANLL) <18 7.80 11 0.731 August 0.1460 1.10 2 0.576
Hodgkin's disease 0-179 29.96 11 0.002 December 0.4100 13.70 2 0.001
Non-Hodgkin lymphoma 0-179 4.48 11 0.954 January 0.0559 0.29 2 0.865
Date ofdiagnosis 0-179 12.92 11 0.299 July 0.0936 4.68 2 0.095
Acute tymphoblastic leukaemia 18-95 12.72 11 0.312 June 0.1178 5.07 2 0.072
>95 6.57 11 0.833 March 0.0158 0.03 2 0.980
Acute non4ymphocyfic leukaemia 0-179 7.11 11 0.790 March 0.0715 0.62 2 0.535
Common acute tymphoblastic leukaernia 0-179 12.13 11 0.354 November 0.1105 1.89 2 0.150
Infant leukaemia (ALL and ANLL) <18 6.83 11 0.813 August 0.3129 5.24 2 0.074
Hodgkin's disease 0-179 10.24 11 0.509 February 0.2232 4.14 2 0.138
Non-Hodgkin lymphoma 0-179 6.62 11 0.829 February 0.0349 0.12 2 0.880
Table 4 Median and interquartile range (IQR) for the lag time, measured to the nearest whole week, by month of first symptom and result of Kruskal-Wallis
test for comparing Lag time between months of first symptom
Diagnosis Jan Feb Mar Apr May June July Aug Sept Oct Nov Dec P-value
ALL
Median (weeks) 3 4 4 4 4 4 4 3 3 3 3 4 0.2123
IOR (weeks) 2-7 2-8 2-7 2-8 2-6.75 2-8.5 2-8 2-6 2-6 2-5.5 1.25-7.75 2-8
c-ALL
Median (weeks) 3 4 4 4 5 2 4 2 2.5 3 3 4 0.1371
IQR (weeks) 1-5 1.5-12.5 1-6.75 2-6.75 2-6 1-3.75 2-6 1-4.75 1-4.75 1.3-5 1-8 2-8
HD
Median (weeks) 11.5 19.5 16 7 22 15 28 10 13 8 11 16 0.3361
IOR (weeks) 5-35.5 7.5-31.25 8-48 3.75-20 13-90 7.75-52.25 10.25-70 4-46 6-36 5.75-22.25 6.5-17.75 6-22
and the Edwards technique was recommended. A correction for
month length was not needed as the numberofcases was far below
the guidelines given by Walter (1994).
The Kruskall-Wallis test was used to identify differences in
median lag times. where lag time is defined as the number of
whole weeks between the recorded date of first symptom and the
date ofdiagnosis. To repeat the analysis by Badrinath et al (1997).
the ratio of summer (May-October) to winter (November-April)
cases was calculated, together with the 95% confidence interval
for the ratio. In all analysis. a P-value of less than 0.05 was taken
to be statistically significant.
RESULTS
For all cases of ALL (including c-ALL). ANLL. HD and NHL
held on the MCTR between 1 January 1954 and 31 December
1996. the date ofdiagnosis was recorded. There were, however. 15
ALL (nine c-ALL), eight ANLL. three HD and six NHL cases who
did not have a known date offirst symptom.
In total. the number of cases identified for this stud) was 1669.
which comprised 1070 ALL (including 309 cases ofdefined c-ALL
diagnosed since 1979). 244 ANLL. 166HI and 189 NHL. Diagnosis
was based on the histological examination ofbone marrow for 92%
ofthe ALL cases. on blood smears for 6% and, forthe remainder. on
examination ofcerebrospinal fluid and investigation at post-mortem.
ForANLL. 90%7 were diagnosed through bone marrow investigation.
9%7 through blood smears and the remainder thdrough investigation at
post-mortem. The diagnosis of HD was made through primary-site
biopsy for 99% of the cases and for 1%7 by investigation at post-
mortem. Fmally. for NHL. 89%- of cases were diagnosed through
primary-site biopsy. 10% through investigation at post-mortem and
the remainder through haeematological examination. Therefore.
detailed diagnostic information based on bone marrow. histology or
cytology was available for 100%7 ofcases.
Tables 1 and 2 show the number of cases by month of first
symptom and month of diagnosis respectively. The results of the
statistical tests for heterogeneity and periodicity in month of first
symptom and month ofdiagnosis are shown in Table 3.
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Edwards' test did not produce any significant results at the 5%
significance level, although ALL (age atdiagnosis 0-179 months).
and the subgroup ALL (age at diagnosis 18-95 months)
approached significance (P = 0.095 and 0.072 respectively). For
the latter subgroup, the peak occurred in June. Interestingly.
the group of infant leukaemias also approached significance
(P = 0.07), with a peak occurring in August/September.
To compare our data with that of Badrinath et al (1997) we
repeated the analysis performed in that study for ALL. Using
date of diagnosis. each case was allocated to either summer
(May-October) or winter (November-April). For the period
1954-96. 574 cases fell into the summer group and 496 into
winter. giving a summer-winter ratio of 1.16 (95% CI 1.04-1.33).
amber which was significantly greater than 1.
Month
Figure 1 Date of first symptom for c-ALL (1979-96): results of Edwards'
method to fit a sinusoidal curve for a 12-month period
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Figure 2 Date of first symptomn for Hodgin's disease (1954-96): results of
Edwards' method to fit a sinusoidal curve for a 12-month period
Results based on month of first symptom
T1he chi-squared test for heterogeneity provided some evidence of
departure from the uniform distribution in the ALL (0-179 months
at diagnosis) group (P = 0.055), but not for any ofthe 'age at diag-
nosis' subgroups. For the c-ALL group, the result was again
borderline (P = 0.056). No significant departures were found in the
groups ANLL. infant leukaemia or NHL. For the HD group. there
was a highly significant departure from the uniform distribution
(P = 0.002), providing strong evidence of a seasonal effect.
Applying Edwards' method to detect a sinusoidal curve within a
12-month period. we found significant results in the c-ALL and HD
groups (P = 0.037 and 0.001 respectively). For the c-ALL group,
the curve had a significant peak in November, with an amplitude of
21.1% (Figure 1) and for the HD group the curve had a significant
peak in December, with an amplitude of41.0% (Figure 2).
Results based on month of diagnosis
Repeating the above techniques on the month of diagnosis. the
heterogeneity test did not detect any departures from the uniform
distribution in any of the diagnostic groups. Likewise. the
Lag time between first symptom and diagnosis
Having found a significant seasonal effect in date offirst symptom
for c-ALL and Hodgkin's disease, we might have expected this
effect to follow on for date of diagnosis also. As this was not the
case. there may be differences in lag time at different times of
the year. However. testing for differences between months for lag
times in the ALL. c-ALL and Hodgkin's disease patient groups
showed no significant differences (Table 4).
DISCUSSION
In order to assess seasonality accurately, it is essential that case
ascertainment is unbiased and has a high level of completeness.
together with consistent and accurate diagnoses throughout the
study period. It has been estimated that the level of completeness
achieved by the MCTR during the first 20 years of operation was
between 95% and 98% (Leck et al. 1976). and ad hoc checks have
indicated that this has been sustained. The MCTR maintains a
collection ofdetailed clinical records and pathology material so that
diagnoses can be reviewed when appropriate. Accuracy and consis-
tency of diagnostic classification are thus ensured. The MCTR
therefore provides a dataset that fulfils all the necessary criteria
There were marked differences in seasonal pattems according to
diagnostic group. For ANLL and NHL. our results have shown no
apparent seasonal variation in date of first symptom or date of
diagnosis. This could indicate that infections do not play a role in
the aetiology of these diseases. However. the involvement of
infections cannot be ruled out and longer, more variable latent
periods may obscure any seasonal trends. Other key factors, such
as heterogeneity. within the disease or causative agents that do not
behave in an epidemic fashion could also account for the lack of
seasonal trends in disease onset.
In contrast, very striking seasonal variation in date of first
symptom was found in HD. producing a highly significant peak in
December. with an amplitude of41.0%. A common virus has long
been suspected as being a key factor in the aetiology ofchildhood
HD (Mueller, 1991). More recent evidence suggests a link
between Epstein-Barr virus (EBV) and HD in children and adults
(Hummel et al. 1992; Armstrong et al. 1993: Khan and Coates,
1994). A recent study (Weinreb et al. 1996) of the EBV status in
childhood HD patients in different countries found that 50% ofthe
UK cases studied were positive for the latent membrane protein 1
(LMP 1). with 100% ofthe 56 cases from Kenya positive for LMP
1. Our results add to the evidence suggesting a viral or other infec-
tive basis for the cause ofthis disease.
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Significant seasonal variation for HD was only found in date of
first symptom and not in date ofdiagnosis, suggesting that date of
first symptom more closely reflects the event thatprecipitates clin-
ical onset ofdisease than date ofdiagnosis. Because ofthe distinc-
tive presenting symptoms ofHD, the date offirst symptom should
provide a reliable indication ofdisease onset. However, there can
be a considerable lag time between date offirst symptom and date
of diagnosis. For example, enlarged nodes may not always be
recognized as neoplastic and may be initially treate as infection.
This variation in date of diagnosis relative to onset of symptoms
may be enough toremove any seasonal pattern visible atthe earlier
point in time.
A much more complex pattern emerged for ALL than for other
diagnostic groups described above. It is known that ALL
comprises a number of diagnostic subgroups characterized by
immunophenotypic markers with associated cytogenetic changes.
Aetiological factors may be different for the various subgroups,
and studies ofcausation ofchildhood leukaemia should attempt to
address this issue. The MCTR includes population-based data
on ALL by immunophenotype from 1979 onwards. Among the
immunophenotyped cases, 74.8% of c-ALL were aged 18-95
months at diagnosis and 86.5% of this age group were c-ALL.
Greaves hypothesis, which relates to the pattem and timing of
infections, is specific for c-ALL and, to try to assess seasonal
variations in c-ALL for the whole time period under study, we
analysed the age group 18-95 months.
For 1979 onwards, we were able to analyse c-ALL regardless of
age at diagnosis. For defined cases of c-ALL, we observed a
significant peak in November, with an amplitude of21.1%, based
on date offirst symptom. However, no significant result was found
using date ofdiagnosis. The reason for the difference between the
two sets of results could be a result of variation in lag time. This
was tested and, although no significant differences were found
between monthly median lag times, a minor variation would be
enough to conceal an underlying sinusoidal curve. The fact that we
found a significant seasonal trend in first symptom for c-ALL
could imply a relatively short latent period between exposure to
the 'precipitating factor' and onset of first symptom. If this were
not the case, the likely variation in latent period would almost
certainly cloud any trend associated with the initial event. The idea
ofa short latent period is consistent with the Greaves' model.
Tlere was no equivalent peak based on date of first symptom
for the age group 18-95 months over the study period. This
apparent discrepancy is probably explained by the proportion of
non c-ALL cases in this group and the fact that a proportion ofc-
ALL cases occurs at other ages. We have shown that the incidence
of ALL inreased dunng the study period and this appears to be
due toc-ALL (Blair and Birch, 1994; Westerbeek et al, submitted).
Therefore, the proportion of c-ALL may have been lower during
the earlier years covered by the study. These factors suggest that
the November peak based on date offirst symptom is specific for
c-ALL and is not present in other subtypes.
The results of the Edwards' test in ALL based on date of diag-
nosis showed peaks of borderline significance in July, for the age
group 0-179 months (P = 0.095), and in June, for the age group
18-95 months (P = 0.072). These findings are consistent with the
recent report by Badrinath andcolleagues (1997) in which a roader
measure of seasonal variation was used. Splitting the year into two
periods, summer (May-October) and winter (November-April),
they found that the ratio of childhood (0-14 years inclusive) ALL
cases diagnosed in summer to those diagnsed in winter was 1.40
(P ' 0.01). Repeating this analysis for our study cases, we found a
lower summer-winter ratio of 1.16 (95% CI 1.04-1.33), which was
still significantly higher than 1. There is some evidence, therefore,
for a summer peak based on diagnosis date considering all ALL
cases, but this was not shown by c-ALL (summer-winter ratio of
1.03,95% CI 0.83-1.29).
For infant leukaemias (ALL and ANLL < 18 months at diag-
nosis), a seasonal peak in date of diagnosis of borderline signifi-
cance was found in August/September (P = 0.074), but there was
no similar finding fordate offirst symptom. Infant leukaemias, by
definition, have a short latent period between first pre-leukaemic
event and clinical onset of disease, and all events leading to
leukaemic transformation may occur pre-natally. Both ALL and
ANLL infant leukaemias can be associated with MLL gene
rearrangements and form a biologically distinct group (Cimino
et al, 1997). In these cases, date ofdiagnosis may be an adequate
marker of biological onset of disease, reflecting the very short
latent period.
Taken together, the set ofresults on ALL may indicate that there
could be a number of underlying seasonal patterns contained
within this diverse diagnostic group. For c-ALL, specifically, we
were able to demonstrate a winter peak associated with onset of
disease-related symptoms, which clearly emphasizes the need to
consider the disease subgroups independently. In the MCTR
series at present, there are insufficient numbers of cases with
immunophenotypes other than c-ALL to enable a true assessment
ofseasonality. The complexity ofseasonal trends in ALL will only
be resolved when full information on diagnostic subtype is
available for a large enough series to permit detailed analyses.
Inconsistencies between results ofpreviously published studies
may be due to differences in definition of diagnostic groups,
differences in reference dates used or genuine regional, national
and international differences (Harris et al, 1987). In this context, if
various subtypes ofALL exhibit different seasonal trends in onset,
variations in the case-mix between populations might account for
at least some ofthe inconsistencies between studies.
In summary, the results of this study strengthen the case for an
association between childhood acute lymphoblastic leukaemia (in
particular c-ALL), Hodgkin's disease and response to an infective
agent, anddemonstrate the needforfurthermolecularand immuno-
histochemical definition of diagnostic groups to be used in future
studies ofchildhood leukaemia and lymphoma aetiology.
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